Vineet Laboratories Limited
Vineet Laboratories Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (API), intermediates, and fine chemicals primarily in India. The company offers intermediates of Lopinavir, Ritonavir, Efavirenz, Nadolol, Glimepiride, Celecoxib, Piroctone Olanine, and other API intermediates. It also provides fine chemicals and reagents, such as isopropyl… Read more
Vineet Laboratories Limited (VINEETLAB) - Total Assets
Latest total assets as of September 2025: ₹906.45 Million INR
Based on the latest financial reports, Vineet Laboratories Limited (VINEETLAB) holds total assets worth ₹906.45 Million INR as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Vineet Laboratories Limited - Total Assets Trend (2017–2025)
This chart illustrates how Vineet Laboratories Limited’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Vineet Laboratories Limited - Asset Composition Analysis
Current Asset Composition (March 2025)
Vineet Laboratories Limited's total assets of ₹906.45 Million consist of 71.3% current assets and 28.7% non-current assets.
| Asset Category | Amount (INR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₹0.00 | 0.7% |
| Accounts Receivable | ₹132.47 Million | 14.0% |
| Inventory | ₹499.71 Million | 52.9% |
| Property, Plant & Equipment | ₹0.00 | 0.0% |
| Intangible Assets | ₹0.00 | 0.0% |
| Goodwill | ₹0.00 | 0.0% |
Asset Composition Trend (2017–2025)
This chart illustrates how Vineet Laboratories Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Vineet Laboratories Limited's current assets represent 71.3% of total assets in 2025, an increase from 48.9% in 2017.
- Cash Position: Cash and equivalents constituted 0.7% of total assets in 2025, down from 48.9% in 2017.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2017.
- Asset Diversification: The largest asset category is inventory at 52.9% of total assets.
Vineet Laboratories Limited Competitors by Total Assets
Key competitors of Vineet Laboratories Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Renxin New Material Co. Ltd. A
SHE:301395
|
China | CN¥1.99 Billion |
|
Engro Corporation Ltd
KAR:ENGRO
|
Pakistan | PKRs765.68 Billion |
|
Fatima Fertilizer Company Ltd
KAR:FATIMA
|
Pakistan | PKRs256.23 Billion |
|
North Huajin Chemical Industries Co Ltd
SHE:000059
|
China | CN¥24.47 Billion |
|
Jiangsu Wujiang China Eastern Silk Market Co Ltd
SHE:000301
|
China | CN¥212.80 Billion |
|
Zangge Holding Co Ltd
SHE:000408
|
China | CN¥16.36 Billion |
|
Sichuan Jinlu Group Co Ltd
SHE:000510
|
China | CN¥2.53 Billion |
|
Jilin Gpro Titanium Industry Co Ltd
SHE:000545
|
China | CN¥2.48 Billion |
Vineet Laboratories Limited - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Vineet Laboratories Limited generates 0.79x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Vineet Laboratories Limited is currently not profitable relative to its asset base.
Vineet Laboratories Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.95 | 1.15 | 1.16 |
| Quick Ratio | 0.12 | 0.40 | 0.63 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | ₹-31.70 Million | ₹ 102.04 Million | ₹ 117.12 Million |
Vineet Laboratories Limited - Advanced Valuation Insights
This section examines the relationship between Vineet Laboratories Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 4.16 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -19.1% |
| Total Assets | ₹945.40 Million |
| Market Capitalization | $2.24 Million USD |
Valuation Analysis
Below Book Valuation: The market values Vineet Laboratories Limited's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Vineet Laboratories Limited's assets decreased by 19.1% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Vineet Laboratories Limited (2017–2025)
The table below shows the annual total assets of Vineet Laboratories Limited from 2017 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-03-31 | ₹945.40 Million | -19.11% |
| 2024-03-31 | ₹1.17 Billion | +0.88% |
| 2023-03-31 | ₹1.16 Billion | -13.31% |
| 2022-03-31 | ₹1.34 Billion | +22.89% |
| 2021-03-31 | ₹1.09 Billion | +27133.17% |
| 2020-03-31 | ₹3.99 Million | -4.35% |
| 2019-03-31 | ₹4.17 Million | +1828.48% |
| 2018-03-31 | ₹216.48K | +96.80% |
| 2017-03-31 | ₹110.00K | -- |